The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) brings together regulatory authorities and the pharmaceutical industry to discuss the scientific and technical aspects of pharmaceutical development.
Through working groups of regulatory and industry experts, ICH produces harmonised technical requirements to ensure the development and registration of safe, effective, and high-quality medicines. Technical guidelines are developed through scientific consensus, with public consultation.
ICH Guidelines are adopted by regulatory authorities and published on the ICH website.
ICH also produces a standardised reference tool for medical terminology (MedDRA) in 27 languages and electronic standards for the transfer of regulatory information (ESTRI).
Founded 35 years ago and registered as a non-profit legal entity under Swiss law in 2015, ICH has finalised nearly 80 Guidelines that are applied by regulatory authorities around the world. ICH has 25 members, 43 observers and a network of close to 700 experts globally.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) brings together regulatory authorities and the pharmaceutical industry to discuss the scientific and technical aspects of pharmaceutical development.
